Exagen Inc. (NASDAQ: XGN) provides autoimmune testing solutions. Exagen transforms the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen Inc. (NASDAQ: XGN) Market Cap: $36.48M; Current Share Price: 2.14 USD Data by YCharts The Company and...
Cosmos Health Inc., (NASDAQ: COSM), is an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications and medical devices through an extensive, established EU and UK distribution network. The Company identifies, acquires, develops and...
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematologic disorders, cancer and rare immune diseases. The Company announced positive topline results from a phase 2 evaluation of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, intended for the...
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and autoimmune diseases has had a great run at the stock market so far this year. Its stocks have almost doubled in 2019 owing...
Vitiligo is an autoimmune condition that is characterized by loss of pigmentation, that affected 150, 000 Americans across all age groups according to a Burden of Skin Disease report commissioned by the American Academy of Dermatology in 2013. The total healthcare costs of Vitiligo were...
